519 related articles for article (PubMed ID: 19029303)
1. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.
Weidensdorfer D; Stöhr N; Baude A; Lederer M; Köhn M; Schierhorn A; Buchmeier S; Wahle E; Hüttelmaier S
RNA; 2009 Jan; 15(1):104-15. PubMed ID: 19029303
[TBL] [Abstract][Full Text] [Related]
2. mTORC2 deploys the mRNA binding protein IGF2BP1 to regulate c-MYC expression and promote cell survival.
Lambrianidou A; Sereti E; Soupsana K; Komini C; Dimas K; Trangas T
Cell Signal; 2021 Apr; 80():109912. PubMed ID: 33388443
[TBL] [Abstract][Full Text] [Related]
3. A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.
Zhu P; He F; Hou Y; Tu G; Li Q; Jin T; Zeng H; Qin Y; Wan X; Qiao Y; Qiu Y; Teng Y; Liu M
Oncogene; 2021 Mar; 40(9):1609-1627. PubMed ID: 33469161
[TBL] [Abstract][Full Text] [Related]
4. Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant.
Lemm I; Ross J
Mol Cell Biol; 2002 Jun; 22(12):3959-69. PubMed ID: 12024010
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides.
Coulis CM; Lee C; Nardone V; Prokipcak RD
Mol Pharmacol; 2000 Mar; 57(3):485-94. PubMed ID: 10692488
[TBL] [Abstract][Full Text] [Related]
7. CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.
Sparanese D; Lee CH
Nucleic Acids Res; 2007; 35(4):1209-21. PubMed ID: 17264115
[TBL] [Abstract][Full Text] [Related]
8. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.
Liao B; Patel M; Hu Y; Charles S; Herrick DJ; Brewer G
J Biol Chem; 2004 Nov; 279(47):48716-24. PubMed ID: 15355996
[TBL] [Abstract][Full Text] [Related]
9. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.
Doyle GA; Betz NA; Leeds PF; Fleisig AJ; Prokipcak RD; Ross J
Nucleic Acids Res; 1998 Nov; 26(22):5036-44. PubMed ID: 9801297
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing MYC.
Ding N; Cao G; Wang Z; Xu S; Chen W
Cancer Sci; 2024 Feb; 115(2):427-438. PubMed ID: 38115228
[TBL] [Abstract][Full Text] [Related]
11. Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA.
Prokipcak RD; Herrick DJ; Ross J
J Biol Chem; 1994 Mar; 269(12):9261-9. PubMed ID: 8132663
[TBL] [Abstract][Full Text] [Related]
12. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.
Noubissi FK; Elcheva I; Bhatia N; Shakoori A; Ougolkov A; Liu J; Minamoto T; Ross J; Fuchs SY; Spiegelman VS
Nature; 2006 Jun; 441(7095):898-901. PubMed ID: 16778892
[TBL] [Abstract][Full Text] [Related]
13. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
Anticancer Res; 2003; 23(3A):2179-83. PubMed ID: 12894594
[TBL] [Abstract][Full Text] [Related]
14. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
15. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.
Stoskus M; Vaitkeviciene G; Eidukaite A; Griskevicius L
Blood Cells Mol Dis; 2016 Mar; 57():30-4. PubMed ID: 26852652
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA NBAT1 suppresses hepatocellular carcinoma progression via competitively associating with IGF2BP1 and decreasing c-Myc expression.
Wei L; Ling M; Yang S; Xie Y; Liu C; Yi W
Hum Cell; 2021 Mar; 34(2):539-549. PubMed ID: 33387362
[TBL] [Abstract][Full Text] [Related]
17. CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.
Ioannidis P; Mahaira LG; Perez SA; Gritzapis AD; Sotiropoulou PA; Kavalakis GJ; Antsaklis AI; Baxevanis CN; Papamichail M
J Biol Chem; 2005 May; 280(20):20086-93. PubMed ID: 15769738
[TBL] [Abstract][Full Text] [Related]
18. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
Shang Y
Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
[TBL] [Abstract][Full Text] [Related]
19. p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression.
Uramoto H; Izumi H; Ise T; Tada M; Uchiumi T; Kuwano M; Yasumoto K; Funa K; Kohno K
J Biol Chem; 2002 Aug; 277(35):31694-702. PubMed ID: 12080043
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Bell JL; Wächter K; Mühleck B; Pazaitis N; Köhn M; Lederer M; Hüttelmaier S
Cell Mol Life Sci; 2013 Aug; 70(15):2657-75. PubMed ID: 23069990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
